Genetics

New drugs more likely to be approved if backed up by genetics

A new drug candidate is more likely to be approved for use if it targets a gene known to be linked to the disease; a finding that can help pharmaceutical companies to focus their drug development efforts. Emily King and colleagues ...

Medical research

Time to end drug company distortion of medical evidence

While there's much to celebrate in medicine, it's now beyond doubt that we have too much of it. Too many tests, diagnoses, pills and procedures are wasting resources that could be better spent meeting genuine need.

Medications

Drugmakers, distributors facing federal opioid probe

At least a half-dozen companies that make or distribute prescription opioid painkillers are facing a federal criminal investigation over whether they violated federal law as they shipped more drugs amid the growing nationwide ...

Medications

Industry executives: Profits drive rising prices for MS drugs

U.S. Medicare patients with multiple sclerosis often pay, on average, nearly $7,000 out of pocket to treat their condition each year. And, even though drug companies have provided no new treatment breakthroughs, the price ...

Medications

New opioid library unveiled to help address epidemic

A new curated library, activated today, provides a centralized toolkit for policymakers, patients and health care professionals working to address the nation's opioid epidemic.

Health

Doctors' group calls for ban on most vaping products

(HealthDay)—The American Medical Association (AMA) is calling for a ban on all e-cigarettes and vaping products not approved by the U.S. Food and Drug Administration to help people quit smoking tobacco cigarettes.

Medications

Oxy sales in China driven by misleading addiction claims

Thousands of lawsuits across the United States have accused a drug company owned by the billionaire Sackler family of using false claims to push highly addictive opioids on an unsuspecting nation, fueling the deadliest drug ...

page 1 from 23